March 04, 2011
Mylan Pharmaceuticals Inc., Teva Biopharmaceuticals USA Inc. and Qualitest Pharmaceuticals Inc. are facing a putative class action in Maryland for allegedly failing to address the potential risks of their now-recalled generic versions of painkillers Darvocet and Darvon.